• >>
  • Pharmaceuticals and Healthcare

Hepatitis B Therapeutics Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240281
21st May, 2018
Region : Global
Pages
CHOOSE LICENCE TYPE

COVID-19


Understand the influence of COVID-19 on the Hepatitis B Therapeutics Market with our analysts monitoring the situation across the globe.






Description

Global Hepatitis B Therapeutics market, by therapy (chemo therapy,  immunosuppressant therapy and nucleoside analogue), product (Hepatitis B vaccine and anti-viral drugs) and distribution channel (hospital pharmacies, online distribution and retail pharmacies). 
Market Scenario:

Hepatitis B is an infectious disease. It is caused by the hepatitis B virus (HBV) which affects the liver. Hepatitis B can cause both acute and chronic infections. 
Hepatitis B is an infection to the liver. It may cause scarring of the organ, liver failure and cancer as well. If it is not treated, it may be fatal. When people come in contact with the blood, open sores, or body fluids of someone who has the hepatitis B virus, it spreads. 


During the initial infection, no symptoms are seen. But some of them develop a rapid onset of sickness with vomiting, yellowish skin, tiredness, dark urine and abdominal pain. These symptoms generally last for few weeks; usually death doesn’t occur in the initial stage. It usually takes 1-6 months for symptoms to begin. The patients who get infected around the time of birth 90% develop chronic hepatitis B, while less than 10% of those infected after the age of five. Out of which, those with chronic disease have no symptoms; but, cirrhosis and liver cancer may develop. Those with chronic disease, these complications result in the death of 15 to 25% of.


By exposure to infectious blood or body fluids, the virus is transmitted. Some of the risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person and travel in countries where the infection rate is high. Cases of Tattooing and acupuncture also have led to a number of cases but, this can be controlled with improved sterility. The hepatitis B viruses is  spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The diagnosis is generally confirmed by testing the blood for parts of the virus and for antibodies against the virus. There are two types of HBV infection Acute and Chronic. For acute hepatitis B there is no treatment.

Increasing demand with innovative products and advanced technological treatments to treat such rare disease provides growth to this market.


Segmentation:
The Hepatitis B Therapeutics market is segmented on the basis of therapy, product, distribution channel and region.
On the basis of product, the market is segmented into chemo therapy,  immunosuppressant therapy and nucleoside analogue.
On the basis of product, the market is segmented into Hepatitis B Vaccine and Anti-viral Drugs.
On the basis of application, the market is segmented into hospital pharmacies, online distribution and retail pharmacies.


Regional Analysis:
Geographically, the Hepatitis B Therapeutics market is segregated in North America, Europe, Asia Pacific, and LAMEA (Latin America, Middle East and Africa). 


Key Players:
The major key players in Hepatitis B Therapeutics market are: Abivax SA, Bristol-Myers Squibb, F. Hoffmann- La Roche, Gilead, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Novartis AG and Novira Therapeutics


Segmentation:
By Therapy
• Chemo Therapy
• Immunosuppressant Therapy
• Nucleoside Analogue
By Product
• Hepatitis B Vaccine
• Anti-viral Drugs
By Distribution Channel
• Hospital pharmacies
• Online Distribution
• Retail Pharmacies
By Geography
• North America
• Europe
• Asia-Pacific
• LAMEA

Research Scope
The study for Global Hepatitis B Therapeutics Market Survey and Trend Research 2018 will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2015-16  Base Year Estimate: 2017  Forecast: 2018 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement, several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

1. Introduction
1.1. Market Definition
1.2. Market Scope


2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions


3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 


4. Therapy Overview
4.1. Introduction 
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Chemo Therapy
4.2.2. Immunosuppressant Therapy
4.2.3. Nucleoside Analogue
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Product Overview
5.1. Introduction 
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. Hepatitis B Vaccine
5.2.2. Anti-viral Drugs
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Distribution Channel Overview
6.1. Introduction 
6.2. Market Size & Forecast, 2015 to 2025
6.2.1. Hospital Pharmacies
6.2.2. Online Distribution
6.2.3. Retail Pharmacies
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Regional Overview
7.1. Introduction
7.2. Market Size & Forecast, 2015 to 2025
7.2.1. North America
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.1.3. Mexico 
7.2.2. Europe
7.2.2.1. UK
7.2.2.2. Germany
7.2.2.3. France
7.2.2.4. Italy 
7.2.2.5. Russia
7.2.2.6. Poland
7.2.2.7. Rest of Europe
7.2.3. Asia-Pacific
7.2.3.1. China
7.2.3.2. India
7.2.3.3. Japan
7.2.3.4. Australia
7.2.3.5. South Korea
7.2.3.6. Rest of Asia-Pacific
7.2.4. LAMEA
7.2.4.1. Saudi Arabia
7.2.4.2. UAE
7.2.4.3. South Africa
7.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Manufacturer/ Vendor Profile
8.1. The following attributes will be considered while profiling key manufacturers in this industry: 
8.1.1. Company Overview
8.1.2. Financial Synopsis
8.1.3. Recent Developments
8.1.4. R&D Investments (if any)
8.1.5. Strategy Overview (Analyst Perspective)
8.1.6. Product Portfolio
8.2. Companies Profiled
8.2.1. Abivax SA
8.2.2. Bristol-Myers Squibb
8.2.3. F. Hoffmann- La Roche
8.2.4. Gilead
8.2.5. GlaxoSmithKline plc.
8.2.6. Johnson & Johnson
8.2.7. Merck & Co.
8.2.8. Novartis AG
8.2.9. Novira Therapeutics
(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 


What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

Report ID :240281

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Report ID :240281

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Hepatitis B Therapeutics Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
  • Impact of COVID on supply/demand scenario, trade landscape & supply chain
  • How market participants are preparing/strategizing to combat the impact
  • How does the short-term & long-term scenario for Hepatitis B Therapeutics Market looks like

Report ID :240281

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports


  • Data Security
  • Your data is safe and secure


  • Vast Report Database
  • We have more than 2 Million reports in our database


  • Client Focused
  • Personalized updates and 24*7 support


  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support


  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie


  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports